Standardization of growth hormone measurement: growth hormone heterogeneity in human pituitary and plasma, G. Baumann; international standards for growth hormone, A.F. Bristow; serum growth hormone measurements in clinical practice - an audit of performance from the UK National External Quality Assessment Scheme, J. Seth, A. Ellis, R. Al-Sadie; variety in growth hormone determinations due to use of different immunoassays and to the interference of growth hormone-binding protein, L. Ebdrup, S. Fisker, H.H. Sorensen, M.B. Ranke, H. Orskov. Consensus of round table discussions: consensus on how to measure growth hormone in serum, M.B. Ranke, H. Orskov, A.F. Bristow, J. Seth, G. Baumann. Evidence-based medicine: towards better decision making, J.S. Pliskin; what randomized trials and systematic reviews can offer decision makers, D.G. Altman; what observational studies can offer decision makers, N. Black; clinical research databases and clinical decision making in chronic diseases, M.G. Kahn; what clinicians can offer - assessing and communicating probabilities for individual patient decision making, D.R.M. Timmermans; patient attitudes and preferences regarding treatment - GH therapy for childhood short stature, B.S. Finkelstein, J. Singh, J.B. Silvers, D. Neuhauser, L. Cuttler; what decision analysis can offer the clinical decision maker, J. Dowie; KIGS and KIMS as tools for evidence-based medicine, M.B. Ranke, J. Dowie.
